Literature DB >> 11192611

Corticosteroids protect oligodendrocytes from cytokine-induced cell death.

R C Melcangi1, I Cavarretta, V Magnaghi, E Ciusani, A Salmaggi.   

Abstract

The present data show that the simultaneous exposure to tumor necrosis factor-alpha (TNFalpha) and interferon-gamma (IFNgamma) induces cell death with characteristics of apoptosis in cultured rat oligodendrocytes; TNFalpha alone was ineffective. We have also demonstrated that different corticosteroids (aldosterone, deoxycorticosterone, dexamethasone and corticosterone) protect rat oligodendrocytes in culture from apoptosis induced by TNFalpha plus IFNgamma. This effect seems to be exerted via the interaction with both type I and type II corticosteroid receptors since all steroids considered are effective. Since oligodendrocyte apoptosis represents an important event in multiple sclerosis and in several demyelinating diseases, the present observations might be considered an interesting background for further researches directed to the possibility of controlling in vivo the death of these cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11192611     DOI: 10.1097/00001756-200012180-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination.

Authors:  Daniella Urbach-Ross; Alexander W Kusnecov
Journal:  Brain Behav Immun       Date:  2007-05-08       Impact factor: 7.217

2.  One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot study.

Authors:  Thomas Müller; Thomas Herrling; Sven Lütge; Lutz Lohse; Gabi Öhm; Katinka Jung
Journal:  Ther Adv Neurol Disord       Date:  2016-03-09       Impact factor: 6.570

3.  Dexamethasone and betamethasone protect against lipopolysaccharide-induced brain damage in neonatal rats.

Authors:  Yi Pang; Lir-Wan Fan; Baoying Zheng; Leigh R Campbell; Zhengwei Cai; Philip G Rhodes
Journal:  Pediatr Res       Date:  2012-02-07       Impact factor: 3.756

4.  Repeated intrathecal triamcinolone acetonide administration in progressive multiple sclerosis: a review.

Authors:  Mazen Abu-Mugheisib; Reiner Benecke; Uwe K Zettl
Journal:  Mult Scler Int       Date:  2011-06-26

5.  Role of neuroactive steroids in the peripheral nervous system.

Authors:  Roberto Cosimo Melcangi; Silvia Giatti; Marzia Pesaresi; Donato Calabrese; Nico Mitro; Donatella Caruso; Luis Miguel Garcia-Segura
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-27       Impact factor: 5.555

6.  Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats.

Authors:  Stefan A Mann; Beatrix Versmold; Romy Marx; Sabine Stahlhofen; Irmgard D Dietzel; Rolf Heumann; Richard Berger
Journal:  J Neuroinflammation       Date:  2008-09-22       Impact factor: 8.322

7.  Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms.

Authors:  Kerstin Hellwig; Franz Josef Stein; Horst Przuntek; Thomas Müller
Journal:  BMC Neurol       Date:  2004-11-07       Impact factor: 2.474

Review 8.  Hormonal Regulation of Oligodendrogenesis II: Implications for Myelin Repair.

Authors:  Jocelyn M Breton; Kimberly L P Long; Matthew K Barraza; Olga S Perloff; Daniela Kaufer
Journal:  Biomolecules       Date:  2021-02-16

9.  Strategies for repair of white matter: influence of osmolarity and microglia on proliferation and apoptosis of oligodendrocyte precursor cells in different basal culture media.

Authors:  Karolina Kleinsimlinghaus; Romy Marx; Meray Serdar; Ivo Bendix; Irmgard D Dietzel
Journal:  Front Cell Neurosci       Date:  2013-12-26       Impact factor: 5.505

Review 10.  Role of Glia in Stress-Induced Enhancement and Impairment of Memory.

Authors:  Jiah Pearson-Leary; Danielle Maria Osborne; Ewan C McNay
Journal:  Front Integr Neurosci       Date:  2016-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.